Zhejiang Hisoar Pharmaceutical Co.,Ltd.’s Net Profit Dropped 8.3% in 2022

Zhejiang Hisoar Pharmaceutical Co.,Ltd. (浙江海翔药业股份有限公司) (002099.SZ) reported a net profit of 86.1 million yuan in 2022, down 8.3% year-on-year.

Meanwhile, the company posted 2.7 billion yuan in revenue, up 8.8% year-on-year.

At the end of the reporting period, it had 8.4 billion yuan in total assets and 2.3 billion yuan in total liabilities, with a liability-to-asset ratio of 27.3%.